Description
Inclusion Criteria:
- * Type 2 Diabetes Mellitus
- * Class II-III New York Heart Association (NYHA) heart failure and reduced ejection fraction (EF) \<50%
- * Age 18-80 years
- * BMI 23-38 kg/m2
- * Glycated hemoglobin (HbA1c) 5.5-10%
- * Blood Pressure (BP) β€ 145/85 mmHg
- * Estimated glomerular filtration rate (eGFR) β₯30 ml/minβ’1.73 m2
- * Stable dose of guideline-directed medications for heart failure
- * Stable body weight (Β±4 pounds) over the last 3 months
Exclusion Criteria:
- * Subjects treated with an SGLT2 inhibitor, a glucagon-like peptide-1 receptor agonist (GLP-1 RA) or pioglitazone
- * Resting heart rate \>120 bpm
- * Systolic BP\>180mmHg and/or diastolic BP \>100mmHg
- * Resting percentage of blood oxygen saturation (SpO2) \< 85%
- * Physical disability preventing safe performance of the exercise protocol.
Ages Eligible for Study:
18 Years to 80 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
No